Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Hum Mutat ; 41(9): 1615-1628, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32579715

RESUMEN

Serine biosynthesis disorders comprise a spectrum of very rare autosomal recessive inborn errors of metabolism with wide phenotypic variability. Neu-Laxova syndrome represents the most severe expression and is characterized by multiple congenital anomalies and pre- or perinatal lethality. Here, we present the mutation spectrum and a detailed phenotypic analysis in 15 unrelated families with severe types of serine biosynthesis disorders. We identified likely disease-causing variants in the PHGDH and PSAT1 genes, several of which have not been reported previously. Phenotype analysis and a comprehensive review of the literature corroborates the evidence that serine biosynthesis disorders represent a continuum with varying degrees of phenotypic expression and suggest that even gradual differences at the severe end of the spectrum may be correlated with particular genotypes. We postulate that the individual residual enzyme activity of mutant proteins is the major determinant of the phenotypic variability, but further functional studies are needed to explore effects at the enzyme protein level.


Asunto(s)
Anomalías Múltiples/genética , Encefalopatías/genética , Retardo del Crecimiento Fetal/genética , Estudios de Asociación Genética , Ictiosis/genética , Deformidades Congénitas de las Extremidades/genética , Microcefalia/genética , Fosfoglicerato-Deshidrogenasa/genética , Transaminasas/genética , Femenino , Feto , Humanos , Recién Nacido , Masculino , Mutación , Serina/biosíntesis
2.
Neurosurg Rev ; 36(3): 483-6, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23584803

RESUMEN

Cerebral cavernous malformations are focal vascular abnormalities that show recurrent intralesional microhemorrhage and may cause focal deficits or seizures in affected patients. These lesions occur in both sporadic and inherited autosomal dominant form. Germline mutations in three different genes have been identified yet. One explanation for the unpredictable individual clinical course with wide variability of the number of developing cerebral cavernous malformations (CCMs) and their rate of progression within CCM families is thought to be based upon a "two-hit" mechanism. However, the direct influence of a heterozygous underlying germline mutation in combination with secondary somatic mutations on a patient's individual clinical course is hard to investigate in vivo. In this context, we present a rare and interesting case of monozygotic twins heterozygous for the CCM1 germline mutation c.730-1G>A and discuss their similar age and type of disease manifestation and their beginning divergent clinical course.


Asunto(s)
Mutación de Línea Germinal/fisiología , Hemangioma Cavernoso del Sistema Nervioso Central/cirugía , Proteínas Asociadas a Microtúbulos/genética , Procedimientos Neuroquirúrgicos/métodos , Proteínas Proto-Oncogénicas/genética , ADN/genética , Electroencefalografía , Femenino , Hemangioma Cavernoso del Sistema Nervioso Central/complicaciones , Humanos , Intrones/genética , Proteína KRIT1 , Linaje , Convulsiones/etiología , Gemelos Monocigóticos , Adulto Joven
3.
Front Cell Dev Biol ; 10: 1020609, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-36726590

RESUMEN

In 2016 and 2018, Chung, Jansen and others described a new syndrome caused by haploinsufficiency of PHIP (pleckstrin homology domain interacting protein, OMIM *612,870) and mainly characterized by developmental delay (DD), learning difficulties/intellectual disability (ID), behavioral abnormalities, facial dysmorphism and obesity (CHUJANS, OMIM #617991). So far, PHIP alterations appear to be a rare cause of DD/ID. "Omics" technologies such as exome sequencing or array analyses have led to the identification of distinct types of alterations of PHIP, including, truncating variants, missense substitutions, splice variants and large deletions encompassing portions of the gene or the entire gene as well as adjacent genomic regions. We collected clinical and genetic data of 23 individuals with PHIP-associated Chung-Jansen syndrome (CHUJANS) from all over Europe. Follow-up investigations (e.g. Sanger sequencing, qPCR or Fluorescence-in-situ-Hybridization) and segregation analysis showed either de novo occurrence or inheritance from an also (mildly) affected parent. In accordance with previously described patients, almost all individuals reported here show developmental delay (22/23), learning disability or ID (22/23), behavioral abnormalities (20/23), weight problems (13/23) and characteristic craniofacial features (i.e. large ears/earlobes, prominent eyebrows, anteverted nares and long philtrum (23/23)). To further investigate the facial gestalt of individuals with CHUJANS, we performed facial analysis using the GestaltMatcher approach. By this, we could establish that PHIP patients are indistinguishable based on the type of PHIP alteration (e.g. missense, loss-of-function, splice site) but show a significant difference to the average face of healthy individuals as well as to individuals with Prader-Willi syndrome (PWS, OMIM #176270) or with a CUL4B-alteration (Intellectual developmental disorder, X-linked, syndromic, Cabezas type, OMIM #300354). Our findings expand the mutational and clinical spectrum of CHUJANS. We discuss the molecular and clinical features in comparison to the published individuals. The fact that some variants were inherited from a mildly affected parent further illustrates the variability of the associated phenotype and outlines the importance of a thorough clinical evaluation combined with genetic analyses for accurate diagnosis and counselling.

4.
Acta Ophthalmol ; 98(3): e316-e321, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-31580008

RESUMEN

PURPOSE: The aim of this study is to report on the phenotype and genotype of five patients diagnosed with Cohen syndrome, an extremely rare autosomal recessive disorder manifesting with mental and physiological defects. METHODS: Five patients from three German families and one Syrian family underwent a comprehensive ophthalmological examination. The scheduled visual acuity measurements, fundus ophthalmoscopy, spectral domain optical coherence tomography (OCT), full-field electrophysiological recordings of scotopic and photopic electroretinograms (ERGs) and colour vision testing could not be carried out in all subjects, because of the mental and physical retardation. The genetic diagnosis was achieved by next-generation sequencing. RESULTS: The ophthalmic and systemic phenotype of the patients is typical for Cohen syndrome including myopia, night blindness, photophobia, fundus pigmentary changes and bull's eye maculopathy. Electroretinograms (ERGs) were extinguished in the four patients, whose recording was possible. Genetic testing revealed homozygous or two heterozygous bi-allelic mutations in the VPS13B (COH1) gene in all five patients, with five different allelic variants observed. The homozygous mutation c.6055_6056delGA; p.Asp2019Glnfs*15 in two sibling patients as well as the homozygous nonsense mutation c.8112C>G;p.Tyr2704* have not previously been reported. CONCLUSIONS: The phenotype of the five patients reported here is typical for Cohen syndrome; however, their genotype is heterogeneous. Two new allelic variants were found to be the causative mutation.


Asunto(s)
Dedos/anomalías , Discapacidad Intelectual/genética , Microcefalia/genética , Hipotonía Muscular/genética , Miopía/genética , Obesidad/genética , Degeneración Retiniana/genética , Retinitis Pigmentosa/genética , Proteínas de Transporte Vesicular/genética , Adolescente , Adulto , Niño , Discapacidades del Desarrollo/complicaciones , Discapacidades del Desarrollo/genética , Discapacidades del Desarrollo/fisiopatología , Femenino , Dedos/fisiopatología , Humanos , Discapacidad Intelectual/complicaciones , Discapacidad Intelectual/fisiopatología , Masculino , Microcefalia/complicaciones , Microcefalia/fisiopatología , Hipotonía Muscular/complicaciones , Hipotonía Muscular/fisiopatología , Mutación , Miopía/complicaciones , Miopía/fisiopatología , Obesidad/complicaciones , Obesidad/fisiopatología , Fenotipo , Degeneración Retiniana/complicaciones , Degeneración Retiniana/fisiopatología , Retinitis Pigmentosa/etiología , Retinitis Pigmentosa/fisiopatología , Adulto Joven
6.
PLoS One ; 13(8): e0201041, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30091983

RESUMEN

Although intellectual disability is one of the major indications for genetic counselling, there are no homogenous diagnostic algorithms for molecular testing. While whole exome sequencing is increasingly applied, we questioned whether analyzing a partial exome, enriched for genes associated with Mendelian disorders, might be a valid alternative approach that yields similar detection rates but requires less sequencing capacities. Within this context 106 patients with different intellectual disability forms were analyzed for mutations in 4.813 genes after pre-exclusion of copy number variations by array-CGH. Subsequent variant interpretation was performed in accordance with the ACMG guidelines. By this, a molecular diagnosis was established in 34% of cases and candidate mutations were identified in additional 24% of patients. Detection rates of causative mutations were above 30%, regardless of further symptoms, except for patients with seizures (23%). We did not detect an advantage from partial exome sequencing for patients with severe intellectual disability (36%) as compared to those with mild intellectual disability (44%). Specific clinical diagnoses pre-existed for 20 patients. Of these, 5 could be confirmed and an additional 6 cases could be solved, but showed mutations in other genes than initially suspected. In conclusion partial exome sequencing solved >30% of intellectual disability cases, which is similar to published rates obtained by whole exome sequencing. The approach therefore proved to be a valid alternative to whole exome sequencing for molecular diagnostics in this cohort. The method proved equally suitable for both syndromic and non-syndromic intellectual disability forms of all severity grades.


Asunto(s)
Discapacidades del Desarrollo/diagnóstico , Discapacidades del Desarrollo/genética , Secuenciación del Exoma/métodos , Exoma/genética , Anomalías Múltiples/genética , Niño , Estudios de Cohortes , Análisis Mutacional de ADN , Femenino , Genes Recesivos , Variación Genética , Humanos , Discapacidad Intelectual/genética , Masculino , Mutación , Malformaciones del Sistema Nervioso/genética , Fenotipo , Embarazo , Análisis de Secuencia de ADN , Síndrome
7.
Clin Dysmorphol ; 26(4): 205-208, 2017 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-28562391

RESUMEN

Pierpont syndrome (OMIM #602342) is a rare disorder characterized by developmental delay, characteristic facial gestalt, hearing loss, and abnormal fat distribution in the distal limbs. A specific mutation in TBL1XR1 [c.1337A>G; p.(Tyr446Cys)] has been described recently in six unrelated patients with Pierpont syndrome. We report on a male child with developmental delay, distinctive facial dysmorphic features, dystrophy, and abnormal fat distribution in the feet, in whom we identified the identical TBL1XR1 mutation. This patient also had additional clinical features including microphthalmia, pendular nystagmus, cryptorchidism, dermal sinus, and peripheral joint laxity, which had not been reported previously in association with Pierpont syndrome. This patient corroborates the assumption that Pierpont syndrome is exclusively caused by the specific TBL1XR1 missense mutation p.(Tyr446Cys) and the additional features broaden the phenotypic spectrum of this rare disorder.


Asunto(s)
Anomalías Múltiples/patología , Preescolar , Humanos , Lactante , Recién Nacido , Masculino , Síndrome
8.
Clin Biochem ; 44(8-9): 722-4, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21420945

RESUMEN

OBJECTIVES: Evaluation of a non-synonymous mutation associated with dihydropyrimidine dehydrogenase (DPD) deficiency. DESIGN AND METHODS: DPD enzyme analysis, mutation analysis and molecular dynamics simulations based on the 3D-model of DPD. RESULTS: The substitution Lys63Glu is likely to affect the FAD binding pocket within the DPD protein and contributes to a near-complete DPD deficiency in a patient with developmental retardation. CONCLUSIONS: Like other DPD variants attenuating FAD binding, Lys63Glu should be included in screening for DPD deficiency.


Asunto(s)
Deficiencia de Dihidropirimidina Deshidrogenasa/orina , Dihidrouracilo Deshidrogenasa (NADP)/genética , Flavina-Adenina Dinucleótido/metabolismo , Mutación Missense/genética , Secuencia de Aminoácidos , Niño , Creatinina/orina , Dihidrouracilo Deshidrogenasa (NADP)/química , Dihidrouracilo Deshidrogenasa (NADP)/metabolismo , Genotipo , Humanos , Masculino , Datos de Secuencia Molecular , Unión Proteica/genética , Unión Proteica/fisiología , Homología de Secuencia de Aminoácido , Timina/orina , Uracilo/análogos & derivados , Uracilo/orina
9.
Ophthalmic Genet ; 29(1): 37-40, 2008 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-18363172

RESUMEN

We report on a young female patient with the clinical features of blepharophimosis-ptosis-epicanthus inversus syndrome (BPES, OMIM 110100) and a balanced chromosome translocation 46, XX, t(2;3)(q33;q23)dn.BPES is a rare autosomal dominant congenital disorder characterized by the eponymous oculo-facial features that are, in female patients, associated either with (type 1 BPES) or without (type 2 BPES) premature ovarian failure. Both types of BPES are caused by heterozygous mutations in the FOXL2 gene, which is located in chromosome band 3q23. Chromosome aberrations such as balanced rearrangements have only rarely been observed in BPES patients but can provide valuable information about regulatory regions of FOXL2. The translocation in this patient broadens our knowledge of pathogenic mechanisms in BPES and highlights the importance of conventional cytogenetic investigations in patients with negative results of FOXL2 mutation screening as a prerequisite for optimal management and genetic counseling.


Asunto(s)
Blefarofimosis/genética , Blefaroptosis/genética , Cromosomas Humanos Par 2 , Cromosomas Humanos Par 3 , Anomalías Cutáneas/genética , Translocación Genética , Blefarofimosis/patología , Blefaroptosis/patología , Rotura Cromosómica , Análisis Mutacional de ADN , Femenino , Proteína Forkhead Box L2 , Factores de Transcripción Forkhead/genética , Humanos , Hibridación Fluorescente in Situ , Lactante , Nariz , Anomalías Cutáneas/patología , Síndrome
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA